4th Quarter - Report

AMERICAN SOCIETY OF NEPHROLOGY for AMERICAN SOCIETY OF NEPHROLOGY

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Address the implementation of the retrospective trend adjustment in the CKCC model Legislation: Explore the establishment of an Officer of Kidney Health and Transplantation at HHS Clarifying HRSA's ability to use OPTN patient waitlist registration fees (HR3433/S Increase support for living donors including through the Honor Our Living Donors Act, The Living Organ Donor Tax Credit Act (H.R. 6171), and the Living Donor Protection Act (H.R. 2923/S. 1384) Increase patient choice and bolster the kidney health workforce by passing the Providing Relief and Stability for Medicare Patients Act of 2023 (H.R. 3674) and the Strengthening Medicare for Patients and Providers Act (HR 2474) Regulatory: Increase kidney health coordination, innovation, and reimbursement through ESRD PPS/QIP, PFS, and ESRD-QIP Measure Set Review Improve transparency and accountability in transplant system to maximize access to kidney transplant, including through the HRSA OPTN Modernization Initiative Establish a federal screening recommendation for kidney diseases

LobbyistCovered position, as disclosed
LAUREN AHEARN —
RACHEL NELL MEYER —
DAVID LEE WHITE —

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3433 (118th), H.R. 2923 (118th), S. 1384 (118th), H.R. 3674 (118th), H.R. 6171 (118th), H.R. 2474 (118th)

Science/Technology SCI

FY 25 Congressional appropriations: -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies Regulatory: Prioritize kidney health research, including inside the NIH Ensure training grants established by the NIH are supportive of the kidney health workforce

LobbyistCovered position, as disclosed
RACHEL NELL MEYER —
RYAN MURRAY Senior Manager of Policy and Government Affairs

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.